We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Viral DNA Extracted from Histology Specimens

By LabMedica International staff writers
Posted on 02 Aug 2011
DNA from archived formalin-fixed, paraffin-embedded (FFPE) tissues can be used for papillomavirus genotyping, but there are potential problems.

These problems for genotyping of the Human papillomavirus (HPV), include paraffin as a physical barrier, DNA cross-linking, and inhibitors of the polymerase chain reaction (PCR).

Investigators at the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) extracted DNA from 10-μm sections from 150 FFPE cancer samples. More...
They combined a commercially available DNA isolation kit, the DNeasy blood and tissue kit, with a heat treatment and evaluated the resulting DNA with regards to HPV typing. Paraffin was removed by xylene and tissue lysed at 56 °C. A second section was directly incubated at 120 °C and subsequently lysed at 65 °C. After spin-column purification, both extracts were tested with a linear array HPV genotyping assay. Cellular DNA yield, HPV16 DNA copies, and PCR inhibitors were assessed by quantitative real-time PCR (qPCR) assays.

Inadequate linear array HPV genotyping assay results were significantly more frequent in xylene-treated than in heat-treated extracts. HPV detection also differed, with 94/150 (62.7%) positives in the xylene treated and 110/150 (73.3%) positive results in the heat-treated extracts. The heat method also yielded 8.2-fold more PCR-amplifiable cellular DNA and 6.5-fold more HPV16 copies, although PCR inhibitors also had a greater effect.

The DNeasy blood and tissue kit used in the study is a product of Qiagen (Valencia, CA, USA) and some improvements may be due to the increased heat during the proteinase K treatment in the kit, which was previously found more effective for tissue lysis. The improvement might also be due to reversal of formaldehyde-induced cross-linking of nucleic acids through the 120 °C incubation. All qPCR assays were performed in a C1000 thermal cycler with a CFX96 real-time system (Bio-Rad; Hercules, CA, USA). The authors concluded that aggressive heat treatment demonstrated an advantage over traditional xylene purification protocols, resulting in higher DNA yields and increased sensitivity for HPV testing. The study was published on July 4, 2011, in the Journal of Molecular Diagnostics.

Related Links:

US Centers for Disease Control and Prevention
Qiagen



New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Microscope
dIFine
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.